124 related articles for article (PubMed ID: 15069010)
1. Effects of losartan in hypertension without vascular disease.
Messerli FH
Ann Intern Med; 2004 Apr; 140(7):W29. PubMed ID: 15069010
[No Abstract] [Full Text] [Related]
2. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Fuchs FD
Lancet; 2002 Jun; 359(9324):2203; author reply 2203-4. PubMed ID: 12091010
[No Abstract] [Full Text] [Related]
3. Summaries for patients. Benefits of losartan in patients with hypertension and left ventricular hypertrophy but no vascular disease.
Ann Intern Med; 2003 Aug; 139(3):I28. PubMed ID: 12899605
[No Abstract] [Full Text] [Related]
4. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
Fournier A; Oprisiu R; Andrejak M; Fernandez L; Achard JM
JAMA; 2003 Feb; 289(6):700; author reply 701. PubMed ID: 12585946
[No Abstract] [Full Text] [Related]
5. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
Messerli FH; Grossman E; Fournier A
JAMA; 2003 Feb; 289(6):700-1; author reply 701. PubMed ID: 12585945
[No Abstract] [Full Text] [Related]
6. The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Olsen MH; Wachtell K; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Lyle PA; Nieminen MS
J Hum Hypertens; 2006 Jun; 20(6):460-4. PubMed ID: 16572193
[No Abstract] [Full Text] [Related]
7. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
Devereux RB; Dahlöf B; Kjeldsen SE; Julius S; Aurup P; Beevers G; Edelman JM; de Faire U; Fyhrquist F; Helle Berg S; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
Ann Intern Med; 2003 Aug; 139(3):169-77. PubMed ID: 12899584
[TBL] [Abstract][Full Text] [Related]
8. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Hamon M
Lancet; 2002 Jun; 359(9324):2199-200; author reply 2203-4. PubMed ID: 12091003
[No Abstract] [Full Text] [Related]
9. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
[TBL] [Abstract][Full Text] [Related]
10. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
Ibsen H; Lindholm LH; Pedersen OL; Dahlöf B; Kjeldsen S
Ugeskr Laeger; 2003 Jan; 165(5):459-62. PubMed ID: 12599844
[TBL] [Abstract][Full Text] [Related]
11. Pulse pressure and antihypertensive agents.
Safar ME; O'Rourke MF
Hypertension; 2005 Aug; 46(2):e6; author reply e6-7. PubMed ID: 16027242
[No Abstract] [Full Text] [Related]
12. The LIFE Trial in 2004.
Beevers DG
J Hum Hypertens; 2004 Jun; 18(6):365. PubMed ID: 15153931
[No Abstract] [Full Text] [Related]
13. Losartan for cardiovascular disease in patient's with and without diabetes in the LIFE study.
Cruickshank JM
Lancet; 2002 Jun; 359(9324):2200-1; author reply 2203-4. PubMed ID: 12091004
[No Abstract] [Full Text] [Related]
14. [Kidney protection leads to heart protection, too].
MMW Fortschr Med; 2006 Aug; 148(33-34):57. PubMed ID: 16981393
[No Abstract] [Full Text] [Related]
15. [Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too].
Traut
Dtsch Med Wochenschr; 2003 Jan; 128(4):161; discussion 161-2. PubMed ID: 12589590
[No Abstract] [Full Text] [Related]
16. [Therapy of hypertension in patients with atrial fibrillation. Sartan is superior to beta-blocker].
MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813983
[No Abstract] [Full Text] [Related]
17. [Results from the LIFE study: promising effects of new hypertensive agents].
Nilsson P; Kahan T
Lakartidningen; 2002 Apr; 99(16):1792-4. PubMed ID: 12043477
[No Abstract] [Full Text] [Related]
18. [To protect the hypertensive patient from complications. Blood pressure lowering is not equal to blood pressure lowering].
MMW Fortschr Med; 2003 Nov; 145(45):51. PubMed ID: 14712789
[No Abstract] [Full Text] [Related]
19. [Isolated systolic hypertension. "AT1 blocker preferred over beta-blocker"].
MMW Fortschr Med; 2002 Sep; 144(38):14. PubMed ID: 12395694
[No Abstract] [Full Text] [Related]
20. Might losartan reduce sudden cardiac death in diabetic patients with hypertension?
Aronow WS
Lancet; 2003 Aug; 362(9384):591-2. PubMed ID: 12944056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
